Meanwhile, SREBF2, the master regulator of cholesterol synthesis, and its target genes responsible for cholesterol biosynthesis such as LSS and SQLE also exhibited an inverse correlation with AML patient survival (Supplementary Fig. 2A). The gene discussed is SREBF2; the disease is acute myeloid leukemia.